Skip to Content

IX 709 (Dexmethylphenidate Hydrochloride Extended-Release 25 mg)

Pill with imprint IX 709 is Beige, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 25 mg. It is supplied by Amneal Pharmaceuticals LLC.

Dexmethylphenidate is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 25 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for IX 709

Dexmethylphenidate Hydrochloride Extended-Release

Imprint
IX 709
Strength
25 mg
Color
Beige
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
00115-1709
Inactive Ingredients
acetyltributyl citrate, ethylcelluloses, hypromelloses, hypromellose acetate succinate 06081224 (3 mm2/s), sucrose, corn starch, magnesium silicate, gelatin, ferrosoferric oxide, shellac, potassium hydroxide, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.